Low-dose oncolytic adenovirus therapy overcomes tumor-induced immune suppression and sensitizes intracranial gliomas to anti-PD-1 therapy

Zineb Belcaid, Cor Berrevoets, John Choi, Edward van Beelen, Eftychia Stavrakaki, Tessa Pierson, Jenneke Kloezeman, Denis Routkevitch, Mariëlle van der Kaaij, Alicia van der Ploeg, Dimitrios Mathios, Stefan Sleijfer, Clemens Dirven, Michael Lim, Reno Debets, Martine L M Lamfers

Research output: Contribution to journalArticleAcademicpeer-review

29 Citations (Scopus)
26 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)1-12
JournalNeuro-Oncology Advances
Issue number1
Publication statusPublished - 3 Feb 2020

Cite this